2 completed, 1 active not recruiting, 1 terminated, 1 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Active not recruiting 1, Terminated 1, Unknown 1 |
Follow linaclotide: new trials by email Literature Review of linaclotide trials Research Report on linaclotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders Linaclotide, Lactulose, Omeprazol - Functional Dyspepsia, Constipation-predominant Irritable Bowel Syndrome | Phase 4 | Unknown | RenJi Hospital | 78 | 2021-01-01 | 2021-12-13 |
| A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C) Linaclotide, Placebo - Irritable Bowel Syndrome Characterized by Constipation | Phase 4 | Terminated | Ironwood Pharmaceuticals, Inc. | 20 | 2016-12-21 | 2021-12-06 |
| An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation Linaclotide - Irritable Bowel Syndrome With Constipation, Chronic Idiopathic Constipation | Phase 4 | Completed | Forest Laboratories | 828 | 2015-11-01 | 2019-08-22 |
| Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation linaclotide or placebo - Chronic Constipation, Diabete Mellitus | Phase 4 | Active not recruiting | Texas Tech University Health Sciences Center, El Paso | 23 | 2015-09-01 | 2026-04-03 |
| Single-dose Linaclotide for Capsule Endoscopy Preparation Linaclotide - Crohn's, Ulcerative Colitis | Phase 4 | Completed | University of Virginia | 30 | 2015-02-01 | 2016-07-14 |
Colitis, Ulcerative (1) · Constipation (1) · Diabetes Mellitus (1) · Gastrointestinal Hemorrhage (1) · Irritable Bowel Syndrome (1)
Forest Laboratories (1) · Ironwood Pharmaceuticals, Inc. (1) · RenJi Hospital (1) · Texas Tech University Health Sciences Center, El Paso (1) · University of Virginia (1)
United States (3) · China (1) · United Kingdom (1)
Irene Sarosiek, MD (1) · Peter Whorwell (1) · Rachel Hays, MD (1) · Shengliang Chen (1) · Wieslaw Bochenek (1)